vs
BALCHEM CORP（BCPC）与HCI Group, Inc.（HCI）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是HCI Group, Inc.的1.1倍（$263.6M vs $246.2M），HCI Group, Inc.净利率更高（39.7% vs 14.9%，领先24.8%），HCI Group, Inc.同比增速更快（52.1% vs 9.8%），过去两年HCI Group, Inc.的营收复合增速更高（9.2% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
HCI集团是一家总部位于美国华盛顿特区的私募股权投资公司，在伊利诺伊州芝加哥设有分支机构，专注于股权投资相关业务，为合作企业提供资本支持与运营赋能，助力企业实现长期发展目标。
BCPC vs HCI — 直观对比
营收规模更大
BCPC
是对方的1.1倍
$246.2M
营收增速更快
HCI
高出42.3%
9.8%
净利率更高
HCI
高出24.8%
14.9%
两年增速更快
HCI
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $246.2M |
| 净利润 | $39.2M | $97.7M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | 58.5% |
| 净利率 | 14.9% | 39.7% |
| 营收同比 | 9.8% | 52.1% |
| 净利润同比 | 16.8% | 3679.2% |
| 每股收益（稀释后） | $1.21 | $7.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCHCI
| Q4 25 | $263.6M | $246.2M | ||
| Q3 25 | $267.6M | $216.3M | ||
| Q2 25 | $255.5M | $221.9M | ||
| Q1 25 | $250.5M | $216.4M | ||
| Q4 24 | $240.0M | $161.9M | ||
| Q3 24 | $239.9M | $175.3M | ||
| Q2 24 | $234.1M | $206.2M | ||
| Q1 24 | $239.7M | $206.6M |
净利润BCPCHCI
| Q4 25 | $39.2M | $97.7M | ||
| Q3 25 | $40.3M | $65.5M | ||
| Q2 25 | $38.3M | $66.2M | ||
| Q1 25 | $37.1M | $69.7M | ||
| Q4 24 | $33.6M | $2.6M | ||
| Q3 24 | $33.8M | $5.7M | ||
| Q2 24 | $32.1M | $54.1M | ||
| Q1 24 | $29.0M | $47.6M |
毛利率BCPCHCI
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
营业利润率BCPCHCI
| Q4 25 | 19.8% | 58.5% | ||
| Q3 25 | 20.4% | 41.9% | ||
| Q2 25 | 20.1% | 42.5% | ||
| Q1 25 | 20.4% | 46.4% | ||
| Q4 24 | 19.8% | 3.6% | ||
| Q3 24 | 20.0% | 8.0% | ||
| Q2 24 | 19.6% | 36.9% | ||
| Q1 24 | 17.4% | 37.5% |
净利率BCPCHCI
| Q4 25 | 14.9% | 39.7% | ||
| Q3 25 | 15.1% | 30.3% | ||
| Q2 25 | 15.0% | 29.8% | ||
| Q1 25 | 14.8% | 32.2% | ||
| Q4 24 | 14.0% | 1.6% | ||
| Q3 24 | 14.1% | 3.2% | ||
| Q2 24 | 13.7% | 26.2% | ||
| Q1 24 | 12.1% | 23.0% |
每股收益（稀释后）BCPCHCI
| Q4 25 | $1.21 | $7.29 | ||
| Q3 25 | $1.24 | $4.90 | ||
| Q2 25 | $1.17 | $5.18 | ||
| Q1 25 | $1.13 | $5.35 | ||
| Q4 24 | $1.03 | $0.32 | ||
| Q3 24 | $1.03 | $0.52 | ||
| Q2 24 | $0.98 | $4.24 | ||
| Q1 24 | $0.89 | $3.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $1.0B |
| 总资产 | $1.7B | $2.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCHCI
| Q4 25 | $74.6M | $1.2B | ||
| Q3 25 | $65.1M | $987.9M | ||
| Q2 25 | $65.4M | $947.2M | ||
| Q1 25 | $49.9M | $754.5M | ||
| Q4 24 | $49.5M | $532.5M | ||
| Q3 24 | $73.7M | $518.8M | ||
| Q2 24 | $63.7M | $445.8M | ||
| Q1 24 | $60.3M | $655.4M |
股东权益BCPCHCI
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.3B | $821.8M | ||
| Q2 25 | $1.3B | $758.6M | ||
| Q1 25 | $1.2B | $522.7M | ||
| Q4 24 | $1.1B | $453.3M | ||
| Q3 24 | $1.2B | $455.3M | ||
| Q2 24 | $1.1B | $447.3M | ||
| Q1 24 | $1.1B | $395.7M |
总资产BCPCHCI
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.7B | $2.3B | ||
| Q2 25 | $1.7B | $2.4B | ||
| Q1 25 | $1.6B | $2.3B | ||
| Q4 24 | $1.6B | $2.2B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $1.9B | ||
| Q1 24 | $1.6B | $1.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $444.4M |
| 自由现金流经营现金流 - 资本支出 | — | $440.8M |
| 自由现金流率自由现金流/营收 | — | 179.0% |
| 资本支出强度资本支出/营收 | — | 1.5% |
| 现金转化率经营现金流/净利润 | 1.72× | 4.55× |
| 过去12个月自由现金流最近4个季度 | — | $771.4M |
8季度趋势，按日历期对齐
经营现金流BCPCHCI
| Q4 25 | $67.3M | $444.4M | ||
| Q3 25 | $65.6M | $26.7M | ||
| Q2 25 | $47.3M | $145.0M | ||
| Q1 25 | $36.5M | $162.0M | ||
| Q4 24 | $52.3M | $331.8M | ||
| Q3 24 | $51.3M | $104.1M | ||
| Q2 24 | $45.0M | $-29.0M | ||
| Q1 24 | $33.4M | $182.0M |
自由现金流BCPCHCI
| Q4 25 | — | $440.8M | ||
| Q3 25 | — | $25.9M | ||
| Q2 25 | — | $144.5M | ||
| Q1 25 | — | $160.3M | ||
| Q4 24 | — | $327.8M | ||
| Q3 24 | — | $103.2M | ||
| Q2 24 | — | $-30.1M | ||
| Q1 24 | — | $181.0M |
自由现金流率BCPCHCI
| Q4 25 | — | 179.0% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | 65.1% | ||
| Q1 25 | — | 74.1% | ||
| Q4 24 | — | 202.5% | ||
| Q3 24 | — | 58.9% | ||
| Q2 24 | — | -14.6% | ||
| Q1 24 | — | 87.6% |
资本支出强度BCPCHCI
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.5% |
现金转化率BCPCHCI
| Q4 25 | 1.72× | 4.55× | ||
| Q3 25 | 1.63× | 0.41× | ||
| Q2 25 | 1.23× | 2.19× | ||
| Q1 25 | 0.98× | 2.32× | ||
| Q4 24 | 1.56× | 128.41× | ||
| Q3 24 | 1.52× | 18.33× | ||
| Q2 24 | 1.40× | -0.54× | ||
| Q1 24 | 1.15× | 3.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
HCI
| Insurance Operation | $218.3M | 89% |
| Reciprocal Exchange Operation | $27.0M | 11% |
